MEU works in collaboration with Manchester University NHS Foundation Trust led by Professor Dave Singh, Head of Airway Pharmacology Group.
The techniques used include cell culture, immunoassays, immunohistochemistry, PCR, flow cytometry and western blotting.
This work is used to develop Biomarkers for early clinical trials.